EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hemodynamic effects of a novel counter-pulsatile system for extracorporeal membrane oxygenation

Marcelo B Bastos iD, Sara Knigge, Bastian Schmack, Liam Schana, Oren Malchin, Felix Schumacher, Ali S Merzah, Aron F Popov, Alexander Weymann, Arjang Ruhparwar, Günes Dogan, Jan D Schmitto

Perfusion · 13.11.2026

DOI: 10.1177/02676591261500979 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Perfusion, online erschienen am 13.11.2026. Verfasst von Marcelo B Bastos und 11 weiteren Autor:innen. Beteiligte Einrichtung: Thoraxcentrum - Interventional Cardiology - Erasmus Medical Center, Rotterdam, The Netherlands. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: PulseCath BV.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and aims Mortality from heart failure is still high despite all the recent advances. Continuous-flow (CF) Veno-arterial Extracorporeal Membrane Oxygenation (VA-ECMO) can temporarily maintain systemic and pulmonary hemodynamics, at the cost of overloading the left ventricle (LV). A new Pulsatile Ventricular Assist Platform (pVAP) could offer a more physiological hemodynamic support.

Methods

6 large porcine models of acute ischemic left ventricular (LV) failure received the pVAP in a VA-ECMO configuration. Invasive systemic and intraventricular hemodynamic measurements were taken with synchronized counter-pulsatile flow (SCPF) and CF support at the same flow rate. The measurements were compared with no support (ON vs OFF) in both modalities.

Results

The pVAP successfully delivered VA-ECMO in acute ischemic heart failure. The device maintained stable hemodynamics and increased the forward cardiac output (CO F ) without overloading the LV and with no change in the LV pressure-volume area (PVA). SCPF, but not CF, was associated with improved LV afterload and ventricular-arterial coupling compared to no support.

Conclusion

The findings suggest that the pVAP is feasible also in a VA-ECMO configuration, supporting hemodynamics with more physiological effect on effect on the LV dynamics.

Schlagwörter

Stichwörter der Autor:innen

VA-ECMOcontinuous flowcounter-pulsationheart failureischemialeft ventricular assist device

Autor:innen und Institutionen

  • Thoraxcentrum - Interventional Cardiology - Erasmus Medical Center, Rotterdam, The Netherlands.
  • PulseCath BV, Utrecht, Netherlands.
  • Department of Cardiac-, Thoracic-, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany.

ORCID-Profile: Marcelo B Bastos

Förderung

  • PulseCath BV

Zitieren

APA

Bastos, M. B., Knigge, S., Schmack, B., Schana, L., Malchin, O., Schumacher, F., Merzah, A. S., Popov, A. F., Weymann, A., Ruhparwar, A., Dogan, G., & Schmitto, J. D. (2026). Hemodynamic effects of a novel counter-pulsatile system for extracorporeal membrane oxygenation. Perfusion. https://doi.org/10.1177/02676591261500979

Vancouver

Bastos MB, Knigge S, Schmack B, Schana L, Malchin O, Schumacher F, et al. Hemodynamic effects of a novel counter-pulsatile system for extracorporeal membrane oxygenation. Perfusion. 2026. doi:10.1177/02676591261500979

BibTeX
@article{Bastos2026,
  author = {Bastos, Marcelo B and Knigge, Sara and Schmack, Bastian and Schana, Liam and Malchin, Oren and Schumacher, Felix and Merzah, Ali S and Popov, Aron F and Weymann, Alexander and Ruhparwar, Arjang and Dogan, Günes and Schmitto, Jan D},
  title = {Hemodynamic effects of a novel counter-pulsatile system for extracorporeal membrane oxygenation},
  journal = {Perfusion},
  year = {2026},
  doi = {10.1177/02676591261500979}
}
Kostenlos starten →